US Patent

US10806791 — Carbohydrate conjugates as delivery agents for oligonucleotides

Composition of Matter · Assigned to Alnylam Pharmaceuticals Inc · Expires 2028-12-04 · 3y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a type of oligonucleotide, specifically a phosphorothioate-modified oligonucleotide, with a defined chemical structure.

USPTO Abstract

The present invention provides a phosphorothioate-modified oligonucleotide comprising a structure shown below: The present invention also provides a phosphorothioate-modified oligonucleotide comprising a structure having formula (CIII):

Drugs covered by this patent

Patent Metadata

Patent number: US10806791
Jurisdiction: US
Classification: Composition of Matter
Expires: 2028-12-04
Drug substance claim: Yes
Drug product claim: No
Assignee: Alnylam Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.